Status:
COMPLETED
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
Lead Sponsor:
Galderma R&D
Conditions:
Acne
Eligibility:
All Genders
13-18 years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to investigate potential differences in treatment adherence by teenagers among four interventions during treatment for acne.
Detailed Description
Same as above.
Eligibility Criteria
Inclusion
- Adolescent subjects with a diagnosis of moderate to severe Acne vulgaris
Exclusion
- Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.), or severe acne requiring more than topical treatment (e.g. oral isotretinoin)
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00437151
Start Date
June 1 2006
End Date
June 1 2007
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States, 27157